Clinical Trial Update: Epacadostat and Pembrolizumab in Patients With GIST [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of epacadostat and pembrolizumab in gastrointestinal stromal tumors was terminated; results/status were posted in June …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Epacadostat (epacadostat)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Columbia University | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: TERMINATED | Results posted: 2024-06-11